Picture courtesy: ANI
New Delhi: With Serum Institute of India (SII)-manufactured Oxford University’s Covishield has been rolled out in India as first COVID-19 vaccine, there are four more waiting for approval from the authorities.
According to Union Health Secretary Rajesh Bhushan, Zydus Cadila, Sputnik V, Biological E and Gennova are currently in advanced clinical trials stage in India. “In the coming days you may see some of these vaccines too approaching the drug controller for emergency use authorisation,” Bhushan was quoted as saying by NDTV.
The Health Ministry said that there will be a 28-day gap between two doses of COVID-19 vaccine and its effectiveness will begin 14 days after the second dose. The health secretary said vaccine effectiveness can be seen only after 14 days. “So we urge people to keep following Covid-appropriate behaviour,” Bhushan said.
ALSO READ: Vaccine To Work After 14 Days Of 2nd Shot, No Option To Choose Between Covishield…
New Delhi: Actress Priyanka Chopra’s recent Instagram post has sparked speculation about a possible crossover…
Berhampur: Renowned pulmonologist of Odisha Dr Narayan Mishra honoured with the prestigious ‘Indian Chest Society-Lifetime…
Mumbai: Two crew members of a fishing vessel have been missing since it collided with…
Raipur: In a major operation, security forces eliminated at least 10 Maoists in an encounter in…
Bhubaneswar: Experts from across India and abroad exchanged knowledge and ideas on latest developments in…
Cuttack Sadar MLA Prakash Sethi's English speech at Bali Jatra inauguration has gone Viral......the caption…
Bhubaneswar: A day after 125th birth anniversary celebration of Harekrushna Mahtab was inaugurated, a war…
Perth: A more sensational script couldn’t have been written for the opening day of the…